Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence

Hillel Yaffe Medical Center

Status: Unknown

Conditions: Pulmonary Embolism; Pulmonary Disease, Chronic Obstructive; Disease Exacerbation; Prothrombin Fragments

Treatments: Other: CT pulmonary angio, blood tests

Study type: Observational

Funder types: Other

Identifiers

NCT01078792

0001-10

Details and patient eligibility

About

To determine the possible association of prothrombin fragments 1+2 elevation with incidents of pulmonary embolism in patients with COPD exacerbation.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• COPD exacerbation
• Able to give informed consent
• Able to perform spirometry

Exclusion criteria

• Known malignancy
• Known hypercoagulable state
• Receiving anticoagulant treatment
• Pregnancy
• Renal failure
• Allergy to Iodine

Trial design

0 participants in 1 patient group

COPD exacerbation

Description:

Patients admitted to hospital with COPD exacerbation

Treatment:

Other: CT pulmonary angio, blood tests